D. E. Shaw & Co »

Arrivent Biopharma shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.5M 369k 23.07
2025-12-31 $4.7M 233k 20.12
2024-09-30 $206k 8.8k 23.50

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
Vanguard Capital Management
General Catalyst Group Management
State Street Corporation
Vivo Capital
Goldman Sachs Group

View all funds holding Arrivent Biopharma